Institute of Urology, Lahey Clinic Medical Center, Burlington, Massachusetts, USA.
J Urol. 2011 Jul;186(1):156-60. doi: 10.1016/j.juro.2011.03.019. Epub 2011 May 14.
We evaluated urethrotomy combined with intralesional injection of the antiproliferative agent mitomycin C for the treatment of severe, recurrent bladder neck contractures after traditional endoscopic management failed. We report our experience with radial urethrotomy and intralesional mitomycin C in patients with recurrent bladder neck contractures.
A retrospective review was performed of patients evaluated for severe, recurrent bladder neck contractures between January 2007 and April 2010. All patients had at least 1 prior failed incision of a bladder neck contracture. Tri or quadrant cold knife incisions of the bladder neck were performed followed by injection of 0.3 to 0.4 mg/ml mitomycin C at each incision site.
A total of 18 patients were treated with bladder neck incision and mitomycin C injection. Preoperatively 4 (22%) patients presented with indwelling Foley catheters while 7 (39%) required a dilation schedule. At a median followup of 12 months (range 4 to 26) 13 patients (72%) had a patent bladder neck after 1 procedure, as did 3 (17%) after 2 procedures and 1 after 4 procedures. All of the patients presenting with a prior indwelling urethral catheter or requiring a dilation schedule had a stable, patent bladder neck.
Management of recurrent bladder neck contractures with radial urethrotomy combined with intralesional mitomycin C resulted in bladder neck patency in 72% of the patients after 1 procedure and in 89% after 2 procedures. Although early results are promising, longer followup and randomized, prospective studies are required to validate these findings.
我们评估了尿道切开术联合抗增殖剂丝裂霉素 C 腔内注射治疗传统内镜治疗失败后的严重、复发性膀胱颈部挛缩。我们报告了我们在复发性膀胱颈部挛缩患者中应用放射状尿道切开术和腔内丝裂霉素 C 的经验。
对 2007 年 1 月至 2010 年 4 月期间评估的严重、复发性膀胱颈部挛缩患者进行回顾性分析。所有患者均至少有 1 次膀胱颈部切开术失败。在每个切开部位进行三或四象限冷刀切开膀胱颈部,然后注射 0.3 至 0.4mg/ml 的丝裂霉素 C。
共有 18 例患者接受了膀胱颈部切开术和丝裂霉素 C 注射治疗。术前有 4 例(22%)患者留置 Foley 导尿管,7 例(39%)需要扩张计划。在中位随访 12 个月(4 至 26 个月)后,13 例患者(72%)在 1 次手术后膀胱颈部通畅,3 例(17%)在 2 次手术后通畅,1 例在 4 次手术后通畅。所有有留置导尿管或需要扩张计划的患者的膀胱颈部均保持稳定通畅。
采用放射状尿道切开术联合腔内丝裂霉素 C 治疗复发性膀胱颈部挛缩,1 次手术后膀胱颈部通畅率为 72%,2 次手术后通畅率为 89%。虽然早期结果令人鼓舞,但需要更长时间的随访和随机、前瞻性研究来验证这些发现。